BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.63B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$337M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$172M |
| 4 |
PPG Industries
PPG
|
+$132M |
| 5 |
AGN
Allergan plc
AGN
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$750M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$525M |
| 3 |
Apple
AAPL
|
+$317M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$275M |
| 5 |
McDonald's
MCD
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.71% |
| 2 | Financials | 8.23% |
| 3 | Healthcare | 5.81% |
| 4 | Consumer Discretionary | 5.23% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHOE
2501
Shoe Station Group
SHOE
$420M
| $76.2K | ﹤0.01% |
6,404
+3,912
| +157% | +$52.1K |
|
|
OME
2502
DELISTED
Omega Protein
OME
| $76.2K | ﹤0.01% |
4,490
+2,683
| +148% | +$41.8K |
|
2503
TG Therapeutics
TGTX
$7.34B
| $76.2K | ﹤0.01% |
7,555
+4,614
| +157% | +$68.7K |
|
|
LDR
2504
DELISTED
Landauer Inc
LDR
| $75.9K | ﹤0.01% |
2,052
+1,255
| +157% | +$46.6K |
|
2505
Waterstone Financial
WSBF
$378M
| $75.9K | ﹤0.01% |
5,628
+3,117
| +124% | +$40.8K |
|
|
UAM
2506
DELISTED
Universal American Corp
UAM
| $75.9K | ﹤0.01% |
11,091
+6,705
| +153% | +$54.3K |
|
|
IBTX
2507
DELISTED
Independent Bank Group, Inc.
IBTX
| $75.8K | ﹤0.01% |
1,973
+1,166
| +144% | +$49.2K |
|
|
KTWO
2508
DELISTED
K2M Group Holdings, Inc
KTWO
| $75.8K | ﹤0.01% |
4,074
+2,609
| +178% | +$57.1K |
|
2509
Arista Networks
ANET
$257B
| $75.7K | ﹤0.01% |
19,792
-39,504
| -67% | -$188K |
|
|
BHR
2510
Braemar Hotels & Resorts
BHR
$139M
| $75.7K | ﹤0.01% |
5,449
+1,847
| +51% | +$26.3K |
|
|
KERX
2511
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $75.4K | ﹤0.01% |
21,420
+12,802
| +149% | +$85.7K |
|
|
HSII
2512
DELISTED
Heidrick & Struggles
HSII
| $75.3K | ﹤0.01% |
3,872
+2,348
| +154% | +$50.7K |
|
|
BKMU
2513
DELISTED
Bank Mutual Corp
BKMU
| $75.2K | ﹤0.01% |
9,786
+5,907
| +152% | +$43.2K |
|
|
TBHC
2514
DELISTED
The Brand House Collective
TBHC
| $75.1K | ﹤0.01% |
3,487
+2,047
| +142% | +$51.4K |
|
2515
NNN REIT
NNN
$8.79B
| $75.1K | ﹤0.01% |
2,070
-14,611
| -88% | -$530K |
|
|
AGEN
2516
Agenus
AGEN
$315M
| $75.1K | ﹤0.01% |
831
-767
| -48% | -$114K |
|
2517
James River Group Holdings
JRVR
$199M
| $74.9K | ﹤0.01% |
2,787
+1,872
| +205% | +$50.7K |
|
2518
HCI Group
HCI
$2.28B
| $74.9K | ﹤0.01% |
1,932
+1,219
| +171% | +$50.5K |
|
2519
DXP Enterprises
DXPE
$3.04B
| $74.9K | ﹤0.01% |
2,745
+1,597
| +139% | +$53.5K |
|
|
CUNB
2520
DELISTED
CU Bancorp
CUNB
| $74.8K | ﹤0.01% |
3,331
+1,933
| +138% | +$42.8K |
|
2521
Leidos
LDOS
$17.6B
| $74.7K | ﹤0.01% |
1,809
-7,735
| -81% | -$323K |
|
|
CSBK
2522
DELISTED
Clifton Bancorp Inc.
CSBK
| $74.7K | ﹤0.01% |
5,384
+3,125
| +138% | +$43.5K |
|
2523
Culp Inc
CULP
$43.8M
| $74.7K | ﹤0.01% |
2,328
+1,469
| +171% | +$46.3K |
|
|
LL
2524
DELISTED
LL Flooring Holdings, Inc.
LL
| $74.6K | ﹤0.01% |
5,680
+3,427
| +152% | +$56.3K |
|
|
BEAT
2525
DELISTED
BioTelemetry, Inc.
BEAT
| $74.3K | ﹤0.01% |
6,074
+3,824
| +170% | +$48.8K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2015 Portfolio in Review
As of Q3 2015, BNP Paribas Financial Markets held 3,791 positions worth $39.9B, up 11% from $35.8B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
BNP Paribas Financial Markets deployed $7.43B of net new capital in Q3 2015, opening 248 new positions and adding to 2,429 existing holdings. Its largest new stake was Allergan plc: 397,434 shares worth $108M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 10% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $525M trimmed.
- BNP Paribas Financial Markets's largest Q3 2015 buy was Allergan plc: 397,434 shares worth $108M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $5.63B increase.
- BNP Paribas Financial Markets's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $525M.
- BNP Paribas Financial Markets fully exited Canadian National Railway in Q3 2015, selling an estimated $750M.
- BNP Paribas Financial Markets's ten largest holdings make up 45% of its $39.9B portfolio in Q3 2015.
- BNP Paribas Financial Markets opened 248 new positions and closed 172 in Q3 2015.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $39.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2015, filed 13 Nov 2015.